NR1I3 and Cholestatic liver disease: CAR is a NR known to strongly activate CYP2B1 expression, and recent evidence suggests that bilirubin may induce translocation of CAR from the cytosol to the nucleus, suggesting a regulatory role of CAR in cholestatic liver disease (Cherrington et al. 2002; Xiong and Yoshinari 2002).